Targeting macrophages in OA nanomedicine: Therapeutic opportunity or delivery delusion? A pragmatic reappraisal

Qing Yao , Beilin Fu , Longfa Kou

Asian Journal of Pharmaceutical Sciences ›› 2026, Vol. 21 ›› Issue (1) : 101127

PDF (376KB)
Asian Journal of Pharmaceutical Sciences ›› 2026, Vol. 21 ›› Issue (1) :101127 DOI: 10.1016/j.ajps.2026.101127
Perspective
research-article
Targeting macrophages in OA nanomedicine: Therapeutic opportunity or delivery delusion? A pragmatic reappraisal
Author information +
History +
PDF (376KB)

Abstract

Cite this article

Download citation ▾
Qing Yao, Beilin Fu, Longfa Kou. Targeting macrophages in OA nanomedicine: Therapeutic opportunity or delivery delusion? A pragmatic reappraisal. Asian Journal of Pharmaceutical Sciences, 2026, 21 (1) : 101127 DOI:10.1016/j.ajps.2026.101127

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Zhang H, Cai D, Bai X. Macrophages regulate the progression of osteoarthritis. Osteoarthritis Cartilage 2020; 28(5): 555-61.

[2]

Kurowska-Stolarska M, Alivernini S. Synovial tissue macrophages in joint homeostasis, rheumatoid arthritis and disease remission. Nat Rev Rheumatol 2022; 18(7): 384-97.

[3]

Yuan Z, Jiang D, Yang M, Tao J, Hu X, Yang X, et al. Emerging roles of macrophage polarization in osteoarthritis: mechanisms and therapeutic strategies. Orthop Surg 2024; 16(3): 532-50.

[4]

Wu CL, Harasymowicz NS, Klimak MA, Collins KH, Guilak F. The role of macrophages in osteoarthritis and cartilage repair. Osteoarthritis Cartilage 2020; 28(5): 544-54.

[5]

Yao Q, Qiu Y, Guan H, Zhang Y, Chen R, Kou L. Nanomedicine-based TRPV1 targeting for osteoarthritis therapy: promise and pitfalls. Expert Opin Drug Deliv 2025; 22(12): 1797-801.

[6]

Steinz MM, Ezdoglian A, Khodadust F, Molthoff CFM, Srinivasarao M, Low PS, et al. Folate receptor beta for macrophage imaging in rheumatoid arthritis. Front Immunol 2022; 13: 819163.

[7]

Kraus VB, McDaniel G, Huebner JL, Stabler TV, Pieper CF, Shipes SW, et al. Direct in vivo evidence of activated macrophages in human osteoarthritis . Osteoarthritis Cartilage 2016; 24(9): 1613-21.

[8]

Ngo W, Ahmed S, Blackadar C, Bussin B, Ji Q, Mladjenovic SM, et al. Why nanoparticles prefer liver macrophage cell uptake in vivo . Adv Drug Deliv Rev 2022; 185: 114238.

[9]

Sousa de Almeida M, Susnik E, Drasler B, Taladriz-Blanco P, Petri-Fink A, Rothen-Rutishauser B. Understanding nanoparticle endocytosis to improve targeting strategies in nanomedicine. Chem Soc Rev 2021; 50(9): 5397-434.

[10]

Liu Y, Ma Z, Wang X, Liang J, Zhao L, Zhang Y, et al. A core-brush nanoplatform with enhanced lubrication and anti-inflammatory properties for osteoarthritis treatment. Adv Sci 2024; 11(47): e2406027.

[11]

Kou L, Huang H, Tang Y, Sun M, Li Y, Wu J, et al. Opsonized nanoparticles target and regulate macrophage polarization for osteoarthritis therapy: a trapping strategy. J Control Release 2022; 347: 237-55.

[12]

Li Y, Li H, Hu Z, Zhang Y, Ding X, Huang X, et al. Phosphatidylserine-decorated delivery platform helps alleviate acute lung injury via potentiating macrophage targeting. J Lipid Res 2025; 66(5): 100799.

[13]

Yao Q, Yang Y, Hu M, Qiu Y, Shi Y, Kou L. Liposomal dexamethasone for intra-articular therapy: functional strategies and clinical progress. J Control Release 2025; 385: 114040.

PDF (376KB)

0

Accesses

0

Citation

Detail

Sections
Recommended

/

〈 〉